Xeroderma Pigmentosum: Relato de Dois Casos
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n2.3247Keywords:
Skin Cancer, Prevenrion of Skin CancerAbstract
Xeroderma pigmentosum is a rare, serious and hereditarian disease. The diagnosis is essentially clinical. So far, there is not a completely efficacious therapy. Based on these facts, the authors review me literature concerning the etiology, etiopathogenesis and pathology of me condition. They report two cases treated in the Hospital Santa Rita of Associação Sulriograndense de Combate ao Câncer emphasizing the clinical and surgical treatment of the disease, and its precancerous and cancerous lesions.
Downloads
References
Bergsma O. Birth deffects compendium. 2nd ed. New York, The National Foundation March of Dimes, 1979, 1088-1089. DOI: https://doi.org/10.1007/978-1-349-05131-1_2
Bocciarelli G, Biggini C, Capurro S, Gari M, Rava C, Santi PL. Xeroderma pigmentoso: considerazioni su un caso di familiaritá. Minerva Chir. 1983; 38: 935-938.
Vogel F, Motulsky AG. Human Genetics. l ed. New York: Springer-Verlag Berlin Heidelberg, 1982; 321-325.
Mckusick VA. Mendelian inheritance in man. 6th ed. Baltimore, The Johns Hopkins University Press, 1983; 976-977.
Mitra S, Narasimharao KL, Pathak IC. Xeroderma pigmentosa. J lndian MedAssoc 1983; 81: 204-205.
Robbins JH, Polinski RJ, Moshell AN. Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum. Ann Neurol. 1983; 13: 682-684. DOI: https://doi.org/10.1002/ana.410130621
Koba,ashi M et al. Skin tumors of Xeroderma pigmentosum. J Dermatol. 198Z 9: 319-322. DOI: https://doi.org/10.1111/j.1346-8138.1982.tb02640.x
Lorette G, Jafar R, Grojean MF, Benatre A. Xeroderma Pigmentosum-like Changes. Arch Dermatol. 1983; 119: 873-874. DOI: https://doi.org/10.1001/archderm.119.11.873
Ndiaye B, Bali MD, StroLl M, N lang 1. Xéroderma pigmentosum: première obrvation sénégalaise. Dakar Med. 1983; 28: 167-172.
Fischer E, Thielmann HW, NeundôrferB, Rentsch FJ, Edler L, Jung EG. Xeroderma pigmentosum patients from germany: clinical symptoms and DNA repair characteristics. Arch Dermatol Res. 1982: 274: 229-247. DOI: https://doi.org/10.1007/BF00403726
Welshimer K, Swift M. Congenital malformations and developmental disabilities in Ataxia-Telangiectasia, fanconi anemia, and xeroderma pigmentosum families. Am J Hum Genet. 1982; 34: 781-793.
Barthelemy H, Claudy AL, Lauras B, Freycon F. Diagnostic anténatal du Xeroderma pigmentosum. Arch Fr Pediatr. 1983: 4& 198.
Guiliot B, Favier C, Guilhou JJ, Meynadier J. Xeroderma pigmentosum: un cas traité par l'association Bêtacarotène-Cantraxantine et rétinoide aromatique. Ann Dermatol Venereol. 1984: III: 65-67.
Meyskens FL, Gilmartin E, Alberts DS et aI. Activity of Isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treatment Reports. 1982; 66: 1315-13 19.
Braun-Falco O, Plewig G, Woiff HH. Dermatologic and Venereologie. lSt ed. New York: Springer-Verlag, 1984: 352, 353, 1025. DOI: https://doi.org/10.1007/978-3-662-00524-8
Braun-Falco O, Goldschmidt H, Lukacs S. Dermatologic Radiotherapy. 1st ed. New York: Springer-Verlag, 1976: 102. DOI: https://doi.org/10.1007/978-1-4612-9880-9_1
Lemaitre A, Romagnolo J, Linker M. La chirurgie dans le traitement du Xeroderma pigmentosum. Acta Stomatol Belg. 1983; 80: 121-130.
